Soluble CD163 is a biomarker for accelerated atherosclerosis in systemic lupus erythematosus patients at apparent low risk for cardiovascular disease

CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis

(2018) Liang Guo et al.   JOURNAL OF CLINICAL INVESTIGATION

Association of Macrophage Inflammation Biomarkers With Progression of Subclinical Carotid Artery Atherosclerosis in HIV-Infected Women and Men

(2017) David B. Hanna et al.   JOURNAL OF INFECTIOUS DISEASES

Urinary soluble CD163 level reflects glomerular inflammation in human lupus nephritis

(2016) Nobuhide Endo et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

CD4+CXCR3+ T cells and plasmacytoid dendritic cells drive accelerated atherosclerosis associated with systemic lupus erythematosus

(2015) Marc Clement et al.   JOURNAL OF AUTOIMMUNITY

Overweight Is a Major Contributor to Atherosclerosis in Systemic Lupus Erythematosus Patients at Apparent Low Risk for Cardiovascular Disease

(2015) Karim Sacre et al.   MEDICINE

Mortality Associated With Systemic Lupus Erythematosus in France Assessed by Multiple-Cause-of-Death Analysis

(2014) Guillemette Thomas et al.   Arthritis & Rheumatology

Relation of Carotid Intima-Media Thickness and Plaque With Incident Cardiovascular Events in Women With Systemic Lupus Erythematosus

(2013) Amy H. Kao et al.   AMERICAN JOURNAL OF CARDIOLOGY

A Panel of Biomarkers Is Associated With Increased Risk of the Presence and Progression of Atherosclerosis in Women With Systemic Lupus Erythematosus

(2013) Maureen McMahon et al.   Arthritis & Rheumatology